Skip to content

Semaglutide Pen Injector [Ozempic]

DRUG6 trials

Sponsors

Woman's, University of Maryland, Baltimore, University of Nottingham, General and Teaching Hospital Celje, Qilu Pharmaceutical Co., Ltd.

Conditions

Arterial StiffnessBiomarkersChemotherapeutic ToxicityDiabetes Mellitus, Type 1Diabetes Type 2Endothelial DysfunctionEndothelial Progenitor CellsFMD

Related Papers